We have selected the following expert medical opinion based on its clarity, reliability and accuracy. Credits: Sourced from the website Patient UK, authored by Dr Colin Tidy, reviewed by Dr Hannah Gronow (see below). Please refer to your own medical practitioner for a final perspective, assessment or evaluation.
Breast cancer is the most common cancer in women. Most cases occur in women over the age of 50 but breast cancer can occur in younger women. If you notice any lump or change to your normal breast, then you should see a doctor promptly. If breast cancer is diagnosed at an early stage, there is a good chance of a cure. In general, the more advanced the cancer (the more it has grown and spread), the less chance that treatment will be curative. However, treatment can often slow the progress of the cancer.
Breast cancer develops from a cancerous (malignant) cell which develops in the lining of a duct or lobule in one of the breasts.
Breast cancer can also develop in men, although this is much less common than breast cancer in women.
Some people are diagnosed when the cancerous cells are still totally within a duct or lobule. These are called carcinoma in situ (or non-invasive breast cancer), as no cancer cells have grown out from their original site.
Most breast cancers are diagnosed when a tumour has grown from within a duct or lobule into the surrounding breast tissue.
These are called invasive breast cancers:
Invasive breast cancers are also divided into those where cancer cells have invaded into local blood or lymphatic vessels and those that have not. Invasive breast cancer is able to spread outside the breast.
Inflammatory breast cancer is an uncommon form of breast cancer but is very aggressive. It is often very advanced by the time of diagnosis. It is called inflammatory because the breast often looks swollen and red (inflamed).
Inflammatory breast cancer tends to be diagnosed in younger women than other forms of breast cancer. Because it is aggressive and often diagnosed at a late stage, the outlook is usually worse than for other breast cancers.
Paget's disease of the breast is a rare type of cancer of the nipple area of the breast. It presents as eczema affecting the nipple and is often associated with an underlying in-situ or invasive carcinoma of the breast.
Many women find that their breasts become more lumpy and tender before periods. Breasts also alter their size and shape with increasing age, pregnancy and marked weight changes. What is important is that you get to know your own breasts - how they look and feel - and report any changes promptly to a doctor.
There are a number of things to look out for which might be breast cancer signs:
The usual first sign is a painless lump in the breast. Note: most breast lumps are not cancerous (malignant). Most breast lumps are fluid-filled cysts or fibroadenomas (a clumping of glandular tissue) which are non-cancerous (benign). However, you should always see a doctor if a lump develops, as the breast lump may be cancerous (malignant).
Other signs which may be noticed in the affected breast include:
The first place that breast cancer usually spreads to is the lymph glands (nodes) in the armpit (axilla). If this occurs, you may develop a swelling or lump in an armpit. If the cancer spreads to other parts of the body then various other symptoms can develop.
Breast tissue is attached to muscle on the chest wall. A tail of breast tissue extends up into the armpit.
The breasts contain:
Like any other cancer, breast cancer can be divided into stages depending on how much the cancer has spread both within the breast and also to other parts of the body. This helps to decide which treatments are best to use and also helps to give some idea of how likely it is that the breast cancer can be cured.
Breast cancer can be divided into the following stages at the time of diagnosis:
A sample of breast cancer tissue can be looked at under the microscope. By looking at certain features of the cells, the cancer can be graded.
Some breast cancer cells have receptors, which allow certain types of hormones or proteins to attach to the cancer cell.
The types of receptor tested for are:
A cancerous (malignant) tumour starts from one abnormal cell. The exact reason why a cell becomes cancerous is unclear. It is thought that something damages or alters certain genes in the cell. This makes the cell abnormal and multiply out of control.
Although breast cancer can develop for no apparent reason, there are certain risk factors which increase the chance that breast cancer will develop.
These include:
About 1 in 20 cases of breast cancer are caused by a faulty gene which can be inherited. The genes BRCA1 and BRCA2 are the most common faulty genes.
If you develop a lump or symptoms which may be breast cancer, a doctor will usually examine your breasts and armpits to look for any lumps or other changes. You will normally be referred to a specialist.
Sometimes a biopsy of an obvious lump (see below) is arranged, but other tests may be done first, such as:
A biopsy is a procedure in which a small sample of tissue is removed from a part of the body. The sample is examined under the microscope, to look for abnormal cells. A specialist may take a biopsy with a needle which is inserted into the lump for some cells to be withdrawn. Sometimes the doctor may be guided as to where to insert the needle with the help of a mammogram or ultrasound scan. Sometimes a small operation is needed to obtain a biopsy sample.
The biopsy sample can confirm or rule out breast cancer. Also, the cells from a tumour can be assessed and tested to determine their grade and receptor status (see above).
If you are confirmed to have breast cancer, further tests may be needed to assess if it has spread - for example:
This assessment is called staging of the cancer. The aim of staging is to find out:
Finding out the stage of the cancer, the grade of the cells and the receptor status of the cancer helps doctors to advise on the best treatment options. It also gives a reasonable indication of outlook.
Treatment options which may be considered include surgery, chemotherapy, radiotherapy and hormone treatment. Often a combination of two or more of these treatments is used.
The treatments used depend on:
You should have a full discussion with a specialist who knows your case. They will be able to give the pros and cons, likely success rate, possible side-effects and other details about the various possible treatment options for your type of cancer.
You should also discuss with your specialist the aims of treatment. For example:
The types of operation which may be considered are:
Radiotherapy is a treatment which uses high-energy beams of radiation which are focused on cancerous (malignant) tissue. This kills cancer cells, or stops cancer cells from multiplying.
For breast cancer, radiotherapy is mainly used in addition to surgery. For example, if you have breast-conserving surgery it is usual to have radiotherapy to the affected breast after the operation. This aims to prevent breast cancer returning in the same breast. When radiotherapy is used in addition to surgery it is called adjuvant radiotherapy.
Some types of breast cancer are affected by the female hormones oestrogen and progesterone. These hormones stimulate the cancer cells to divide and multiply. Most oestrogen and progesterone are made by the ovaries. Treatments which reduce the level of these hormones, or prevent them from working, are commonly used in people with breast cancer.
Hormone treatment works best in women with hormone-responsive breast cancer; however, it sometimes works in cancers classed as non-hormone-responsive.
Hormone treatments include:
Chemotherapy is a treatment of cancer by using anti-cancer medicines which kill cancer cells, or stop them from multiplying.
When chemotherapy is used in addition to surgery it is known as adjuvant chemotherapy. For example, following surgery you may be given a course of chemotherapy. This aims to kill any cancer cells which may have spread from the main tumour site.
Chemotherapy is sometimes given to shrink a tumour before surgery so that surgery may have a better chance of success and also a smaller operation may be performed. This is known as neoadjuvant chemotherapy. The type of chemotherapy given may depend on the type of cancer.
New gene tests are being developed to help doctors decide which women will benefit the most from chemotherapy.
Chemotherapy may also be used for some women to treat breast cancer which has spread to other areas of the body.
The treatment plan that may be advised can vary greatly from case to case as optimal treatment can depend on many different factors.
The outlook (prognosis) has greatly improved in recent years. Deaths from breast cancer are now at the lowest ever in 40 years. This is mainly due to the improvements in the treatment of breast cancer. The outlook is best in those who are diagnosed when the cancer is still small and has not spread. More breast cancers are also now being diagnosed and treated at an early stage. In general, the more advanced the cancer (the more it has spread) then the less chance that treatment will be curative.
The treatment of cancer is a developing area of medicine. New treatments continue to be developed and the information on outlook above is very general. The specialist who knows your case can give more accurate information about your particular outlook and how well your type and stage of cancer is likely to respond to treatment.
Women in the UK aged between 50 and 70 are invited to have a routine mammography every three years. This is gradually being extended to women aged 47-73.
Mammography is a special X-ray test and aims to detect breast cancer at an early stage when treatment is most likely to be curative.
Genetic testing and mammography screening (and preventative treatments in some cases) may also be offered to younger women with a strong family history of breast cancer. See your doctor if you feel this applies to you.
A lot of breast cancers are detected at an early stage, by breast screening. However, a small number are not. Some women may have developed breast cancer before they have their first mammogram and some may develop breast cancer between mammograms. All women of every age should be breast aware. That is, get to know how your breasts and nipples normally look and feel. Try to recognise any changes that occur before and after your periods. See your GP if you notice any changes, lumps, or other abnormalities in your breasts or nipples. Don't wait until your next scheduled screening appointment.
There is some evidence that regular exercise may reduce your risk of breast cancer by as much as a third. If you have been through the menopause, it is particularly important you are not overweight or obese. This is because being overweight causes more oestrogen to be produced, which can increase the risk of breast cancer.
Studies have shown that women who breast-feed their children are less likely to develop breast cancer than those who do not. The most likely reason for this is that women do not produce an egg (ovulate) as regularly while they are breast-feeding and oestrogen levels remain stable.
There are also two preventative types of treatment - surgery to remove the breasts (mastectomy) or medication. Surgery can be used to treat breast cancer as well as reduce the chances of developing it. By removing as much breast tissue as possible, a mastectomy can reduce your risk of breast cancer by up to 90%. Like all operations there can be several complications, and this is not an easy step to take. If genetic testing has shown you are one of the small number of women from a high-risk family, you will need an in-depth discussion with your doctors, before deciding to have this operation.
Tamoxifen is available on the NHS for women who have an increased risk of developing breast cancer. Tamoxifen can be used in women who have been through the menopause as well as for women who are still having periods. A different medicine called raloxifene can also be used in women who have been through the menopause. Women who have already had both breasts removed won't be offered these medications because their risk of developing breast cancer is very small.
A course of treatment with tamoxifen or raloxifene will usually involve taking a tablet every day for five years. Currently, these two medications are not licensed for the purpose of reducing the risk of breast cancer. However, they can still be used if you understand the benefits and risks and your doctor believes the treatment will be helpful.
Dr Colin Tidy
MBBS, MRCGP, MRCP, DCH
Dr Colin Tidy qualified as a doctor in 1983 and he has been writing for Patient since 2004. Dr Tidy has 25 years’ experience as a General Practitioner. He now works as a GP in Oxfordshire, with a special interest in teaching doctors and nurses, as well as medical students. In addition to writing many leaflets and articles for Patient, Dr Tidy has also contributed to medical journals and written a number of educational articles for General Practitioner magazines.
Dr Hannah Gronow
MB ChB
Hannah qualified in 1997. She joined EMIS (patient.info) as a peer reviewer in August 2006. Currently a part time salaried GP in Paignton and moving to a practice in Brixham in 2018. Hannah is about to start a diploma in psychotherapy. Her interests include oncology and pharmacology.
_______________________________________________________________________________________________________________________
Are you a healthcare practitioner who enjoys patient education, interaction and communication?
If so, we invite you to criticise, contribute to or help improve our content. We find that many practicing doctors who regularly communicate with patients develop novel and often highly effective ways to convey complex medical information in a simplified, accurate and compassionate manner.
MedSquirrel is a shared knowledge, collective intelligence digital platform developed to share medical expertise between doctors and patients. We support collaboration, as opposed to competition, between all members of the healthcare profession and are striving towards the provision of peer reviewed, accurate and simplified medical information to patients. Please share your unique communication style, experience and insights with a wider audience of patients, as well as your colleagues, by contributing to our digital platform.
Your contribution will be credited to you and your name, practice and field of interest will be made visible to the world. (Contact us via the orange feed-back button on the right).
Disclaimer:
MedSquirrel is a shared knowledge, collective intelligence digital platform developed to share medical knowledge between doctors and patients. If you are a healthcare practitioner, we invite you to criticise, contribute or help improve our content. We support collaboration among all members of the healthcare profession since we strive for the provision of world-class, peer-reviewed, accurate and transparent medical information.
MedSquirrel should not be used for diagnosis, treatment or prescription. Always refer any questions about diagnosis, treatment or prescription to your Doctor.